The latest financial statement is for the year ending 2025-12-31.
| Cash Flow | 2025-12-31 |
|---|---|
| Net income | 63,058 |
| Depreciation on premises and equipment | 1,824 |
| Core deposit intangible amortization | 3,791 |
| Accretion of net discounts and deferred loan fees | 21,273 |
| Amortization of discounts of debt securities | -1,450 |
| (gain) loss on sale of loans | 577 |
| Loss on sale and disposal of fixed assets | -1 |
| Loans originated for sale | 8,955 |
| Proceeds from sales of and principal collected on loans held for sale | 9,569 |
| (reversal of) provision for credit losses | -8,823 |
| Deferred income tax expense (benefit) | 11,482 |
| Impairment charges of right-of-use assets | 0 |
| Stock-based compensation | 5,822 |
| Income from bank owned life insurance | 2,336 |
| Loss on sale of other real estate owned | -862 |
| Valuation allowance on other real estate owned | 0 |
| Net decrease in other items | -4,295 |
| Net cash provided by operating activities | 57,290 |
| Net cash acquired in business combination | 0 |
| Proceeds from bank owned life insurance death benefits | 1,572 |
| Proceeds from sale of debt securities available for sale | 0 |
| Proceeds from maturities and paydowns of debt securities available for sale | 38,396 |
| Purchases of debt securities available for sale | 122,364 |
| Purchases of debt securities held to maturity | 0 |
| Purchases of restricted stock | 103 |
| Net (contributions) distributions of stock investments | 680 |
| Net repayment of loans | -98,357 |
| Proceeds from sale of loans held for investment | 13,500 |
| Proceeds from sale of other real estate owned | 1,421 |
| Purchases of premises and equipment | 346 |
| Net cash provided by investing activities | 29,753 |
| Net decrease in deposits | -28,142 |
| Repayment of federal home loan bank advances | 0 |
| Repayment of other borrowings | 38,000 |
| Proceeds from exercise of stock options | 132 |
| Repurchase of shares in settlement of restricted stock units | 2,663 |
| Repurchase of common stock under authorized stock repurchase program | 3,366 |
| Common stock dividends | 3,253 |
| Net cash used in financing activities | -75,292 |
| Net change in cash and cash equivalents | 11,751 |
| Cash and cash equivalents at beginning of year | 388,162 |
| Cash and cash equivalents at end of year | 399,913 |
California BanCorp CA (BCAL)
California BanCorp CA (BCAL)